Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Time to Recurrence After Ranibizumab or Aflibercept Loading for Age-related Macular Degeneration

NCT02126904 is registered in ClinicalTrials.gov with Yokohama City University Medical Center as lead sponsor.

NCT NCT02126904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02126904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Time to Recurrence After Ranibizumab or Aflibercept Loading for Age-related Macular Degeneration
Lead sponsor
Yokohama City University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
Not reported
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the injection burden